Building integrity into your analytical workflow for pharmaceutical development
Integrity in the analytical workflow for pharmaceutical development relies on understanding how both your processes and also the physical characteristics of your materials affect your product’s performance. This starts as early as during the product design phase, by determining how the product delivers patient benefit, and which critical material attributes (CMAs) and critical process parameters (CPPs) will enable you to achieve this.
Different analytical techniques can provide the information you need at different stages of the development process. Fundamental understanding about how components behave and interact relies on detailed material characterization, such as particle size, shape and chemical form. From this, you can progress to determining what physical properties are critical to quality (CTQ) and how it is best to measure and control them during process scale up, through to manufacture.
In this webinar, we will discuss how range of material characterization techniques, including laser diffraction and analytical imaging can help build integrity in your analytical workflow, from discovery right through to QC.
Date: January 31 2019 - January 31 2019
Time: 10:30 - 11:30 (GMT-05:00) Eastern [US & Canada]
Event type: Webinar - Live
Speakers Anne Virden - Technical Support Supervisor - Imaging +amp;amp; Diffraction
Who should attend?
Those working within pharmaceutical development/manufacture who are interested in building their knowledge of the fundamentals of materials analysis and understanding how this can impact on and optimize both their products and processes.
What will you learn?
How particle characterization fits into the pharmaceutical development workflow.
How particle characteristics affect processes such as dissolution, stability and flowability.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019